17/10/2026
We are thrilled to celebrate a major milestone with our partner Cellmax on the successful launch of their locally developed wound care products — Cellmax Freeze-Dried Powder and Cellmax Wound Spray.
After more than eight years of dedicated research, RM7 million in investment, rigorous clinical studies (including trials with Kuala Lumpur Hospital on complex, chronic, and hard-to-heal wounds), and successful registration with the Medical Device Authority, these products are now ready to support patients recovering from chronic ulcers, traumatic injuries, and surgical wounds.
This achievement marks an important step forward in cellular therapy and regenerative wound management. We at Cellaax are proud to have been part of the clinical trial journey and to stand alongside Cellmax in bringing Malaysian-developed, high-quality solutions to patients while reducing reliance on imported medical products.
Congratulations to the entire Cellmax team — Managing Director Loke Mei Chan, Chief Scientific Officer Dr Azizi Ayob, and everyone involved — on this well-deserved success, including their Innovathon win and National Intellectual Property Award recognition.
Here’s to continued collaboration and advancing the future of cellular therapy together.
